Time for a change in drug licensing requirements?

被引：7

作者：

Michael F. Drummond

机构：

[1] University of York,Centre for Health Economics

来源：

关键词：

Economic Evaluation; Appraisal Process; License Requirement; Pharmaceutical Benefit Advisory Committee; Clinical Trial Programme;

D O I：

10.1007/s10198-002-0119-4

中图分类号：

学科分类号：

摘要：

引用

页码：137 / 138

页数：1

共 6 条

[1] Freemantle N(1995)Promoting cost-effective prescribing: Great Britain lags behind British Medical Journal 310 955-956
[2] Henry D(1996)Guidelines for authors and peer reviewers of economic submissions to the BMJ British Medical Journal 313 275-283
[3] Maynard A(undefined)undefined undefined undefined undefined-undefined
[4] Torrance G(undefined)undefined undefined undefined undefined-undefined
[5] Drummond M F(undefined)undefined undefined undefined undefined-undefined
[6] Jefferson T O(undefined)undefined undefined undefined undefined-undefined